|
|
||||||||||
|
J Am Coll Cardiol, 2006; 48:805-811, doi:10.1016/j.jacc.2006.03.055
(Published online 24 July 2006). © 2006 by the American College of Cardiology Foundation |

* Cleveland Clinic Foundation, Cleveland, Ohio
Toronto General Hospital, Toronto, Ontario, Canada.
Manuscript received January 17, 2006; revised manuscript received March 5, 2006, accepted March 20, 2006.
* Reprint requests and correspondence: Dr. Patrick J. Tchou, Section of Cardiac Pacing and Electrophysiology, Department of Cardiovascular Medicine/F15, 9500 Euclid Avenue, Cleveland, Ohio 44195. (Email: tchoup{at}ccf.org).
| Abstract |
|---|
|
|
|---|
BACKGROUND: Stun guns are increasingly used by law enforcement officials to restrain violent subjects, who are frequently intoxicated with cocaine and other drugs of abuse. The interaction of cocaine and the stun gun on VF induction is unknown.
METHODS: We tested five adult pigs using a custom device built to deliver multiples of standard neuromuscular incapacitating (NMI) discharge that matched the waveform of a commercially available electrical stun gun (Taser X-26, Taser International, Scottsdale, Arizona). The NMI discharges were applied in a step-up and step-down fashion at 5 body locations. End points included determination of maximum safe multiple, minimum VF-inducing multiple, and ventricular fibrillation threshold (VFT) before and after cocaine infusion.
RESULTS: Standard NMI discharges (x1) did not cause VF at any of the 5 locations before or after cocaine infusion. The maximum safe multiple, minimum VF-inducing multiple, and VFT of NMI application increased with increasing electrode distance from the heart. There was a 1.5- to 2-fold increase in these values at each position after cocaine infusion, suggesting decreased cardiac vulnerability for VF. Cocaine increased the required strength of NMI discharge that caused 2:1 or 3:1 ventricular capture ratios at all of the positions. No significant changes in creatine kinase-MB and troponin-I were seen.
CONCLUSIONS: Cocaine increased the VFT of NMI discharges at all dart locations tested and reduced cardiac vulnerability to VF. The application of cocaine increased the safety margin by 50% to 100% above the baseline safety margin.
| |||||||||||
The ventricular fibrillation (VF) threshold of Taser shocks has been reported to be relatively high and directly proportional to body mass (14). The interplay of cocaine and NMI current on the induction of arrhythmias is not known. This article examines cocaines effects on VF inducibility by NMI current when applied to various body locations in a pig model.
| Methods |
|---|
|
|
|---|
|
Position of the darts. Human field experience has shown that the posterior and anterior upper trunk regions were the most common dart attachment sites (2, personal communication, Taser International, Scottsdale, Arizona). Figure 2 identifies the five different paired-dart positions tested on the pig body, labeled Positions A through E. Because we hypothesized that current application nearest the heart and along its axis would be the most arrhythmogenic, we tested Position A at the beginnings of the two series. The point of maximum impulse (PMI), typically located slightly left of the xyphoid process, was palpated and confirmed with auscultation and echocardiography. The sequence of testing the remaining four sites was randomized. Two darts were inserted to full depth at the mentioned sites. The mean distance of the PMI dart tip from the epicardial surface measured by echocardiography was 18 ± 4 mm.
|
Determination of VF threshold and ventricular capture. Standard NMI discharge is a 5-s application equivalent to a single Taser X-26 application. Testing was started with a standard discharge (x1) followed by discharges of increasing stored charge in a step-up fashion until VF was induced. The stored charge was increased for each step by multiples of the standard capacitor (x5, x10, and multiples of x10 up to x100). After the first VF induction, the capacitances were decreased in reversed sequence with the addition of x7 and x2 when needed until 3 sequential discharges of equal stored charge did not induce VF. Surface electrocardiogram (ECG) leads II and V1 were recorded. A right ventricular intracardiac bipolar electrogram (EP Technologies, Boston Scientific Ltd., Sunnyvale, California) was monitored to assess ventricular capture during NMI application. When ventricular capture occurred, it usually had a fixed ratio to the delivered pulses. Thus, the frequency of ventricular capture was quantified as the ratio of NMI pulses to each ventricular capture beat. Pigs were defibrillated on VF induction with a 300-J direct current biphasic shock. The animals were rested 3 min between each discharge without VF and 15 min with VF induction.
Blood samples. Arterial and venous blood samples were obtained before starting NMI application, after the first NMI application at Position A (to assess effects of standard NMI applications), before and 30 min after the infusion of cocaine, and at the end of the entire experiment.
Definitions of variables. Minimum VF-inducing multiple (minVFIM) was defined as the lowest NMI discharge multiple that induced VF at least once in 3 tries. Maximum safe multiple (maxSM) was defined as the highest discharge multiple that could be applied 3 times without VF induction. Ventricular fibrillation threshold (VFT) was defined as the average of these 2 values. The NMI discharge multiples at which 2:1 and 3:1 ventricular captures were seen are reported here. These 2 ratios were chosen because 3:1 capture was the highest capture frequency that did not induce VF, whereas 2:1 capture always induced VF.
Data analysis. All continuous variables were summarized by their means and standard deviations. The effect of cocaine on maxSM, minVFIM, and VFT was tested using the paired t test. A general linear model for repeated measures with a difference contrast was used to compare the Taser and cocaine effects on hemodynamic and metabolic data, cardiac markers, and ECG data. The Bonferroni adjustment was used to correct for between- and within-subjects factors. A level of p < 0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
2:1. The VF was consistently inducible whenever the ventricular capture ratio was
2:1. No VF induction was noted when the ventricular capture was
3:1. A greater degree of ventricular capture at lower strengths was seen at Position A than at other locations. This correlated with our finding that VF was induced with the lowest minVFIM at this location. Application strength multiples of x40 and higher were needed on the back (Position E) to accomplish similar ventricular capture ratios. Standard NMI discharge at Position A did not induce VF in any animal despite ventricular capture ratios ranging from 6:1 through 3:1, nor was VF induced with standard x1 NMI application at any of the other four locations with or without cocaine. The NMI output multiples at which 2:1 and 3:1 ventricular capture ratios were seen for the various dart positions are shown in Figure 3. Cocaine increased the required strength of NMI discharge that caused a 2:1 or 3:1 ventricular capture ratio at all positions.
|
Serum creatine kinase (CK) levels increased from 553 ± 72 U/l at baseline to 2,699 ± 828 U/l after the baseline precocaine VF induction testing (p = 0.04). This increase reflects cumulative delivery of more than 1,000 times the standard NMI discharge and is most likely related to multiple intense muscular contractions. There was a milder increase in CK levels after cocaine infusion before further NMI application (3,058 ± 984 U/l vs. 2,699 ± 828 U/l, p = 0.21). These CK values reached a level of 13,273 ± 6,163 U/l (p = 0.02) at the end of the experiment, when a cumulative NMI application of more than 2,000 times the standard strength had been delivered. No significant changes were seen in CK-MB throughout the experiment.
Pathologic and histopathologic findings. The mean weight of these hearts was 215 ± 25 g. There was no gross evidence of myocardial necrosis or damage. Detailed histologic analysis showed no structural changes in 1 animal and some myocardium, conduction system, or endocardium changes in 4 animals (Table 2). The findings seen in these animals were limited to the ventricular subendocardial region, localized to focal areas not exceeding 5% of the total myocardium.
|
| Discussion |
|---|
|
|
|---|
How NMI discharge would interact with the effects of cocaine on the inducibility of cardiac arrhythmias has not been reported. Given the increased incidence of cocaine intoxication in subjects being restrained with Taser weapons by law enforcement officers, it is important to assess the effect of cocaine on ventricular arrhythmia induction by NMI devices. Our study showed that VF could not be induced using the standard 5-s Taser discharge applied to a pigs body surface even at the most sensitive area tested. Clearly, increasing the delivered charge beyond the standard NMI application can induce VF. The sensitivity to VF induction at increasing strengths of application varied depending on the dart locations over the body. As might be expected, the most sensitive dart location seemed to be the PMI-to-sternal notch (SN) axis (Position A). This is most likely because of the proximity of one electrode to the heart (PMI) and bracketing of the heart by the other electrode (SN). The tip of the electrode at the PMI position was only 1 to 2 cm from the myocardium. With increasing distance of these electrodes from the heart, VF thresholds increased precipitously. Ventricular fibrillation could be induced only at very high multiples of NMI discharge when applied to the back of the trunk. Thus, it is likely that induction of VF is directly related to current density at the myocardium and pulse width of the delivered impulses.
Our study is the first to describe capture of ventricular myocardium during application of NMI pulses. Although it is difficult to appreciate myocardial capture on the surface ECG, the recording from the right ventricular bipolar electrogram can show myocardial capture. When rapid capture of the myocardium occurred, the blood pressure recordings also showed a precipitous decrease. An example of such observations is shown in Figure 4. Our observations indicate that rapidity of myocardial capture may play a significant role in the induction of VF. In our experiments, occurrences of 2:1 or more frequent capture were associated with induction of VF. Such capture was not seen even at Position A during delivery of the standard discharge. This observation probably explains the lack of VF induction with the standard discharge at all positions.
|
The very limited histopathologic findings reported here suggest that damage to the heart by the applied NMI current is minimal even after cumulative doses of over 2,000 times standard NMI discharges. Cardiac pathologies associated with high-voltage and high-current exposures have been well documented in multiple prior reports (2024). Focal changes affecting the myocardium are described as extensively dispersed throughout the ventricles and atria. These injuries are seen with much higher current than that delivered by NMI devices. Thus, it is not surprising that we did not observe such injury to the heart in our histopathological analysis. Toxic effects of cocaine on the myocardium can result in scattered foci of necrosis, contraction band necrosis, myocarditis, and foci of myocardial fibrosis (8,25,26). It is impossible to separate the cocaine effect from that of NMI application when assessing the minor histologic findings reported here. Given the large number of NMI applications made during these experiments, it would be difficult to extrapolate any of our histologic findings to a clinically relevant scenario.
Extending animal data to human beings should always be done with caution. However, pigs frequently have been used in fibrillation and defibrillation threshold studies with the results generalized to humans. The results of our study and the few prior animal studies (14) would suggest that NMI discharge at the standard 5-s application is unlikely to cause life-threatening arrhythmias, at least in the normal heart. Our data regarding myocardial capture, however, suggest the potential for induction of ventricular tachycardia in subjects with substrate for ventricular tachycardia, especially if one of the electrodes were to come within a few centimeters of the myocardium, with the other positioned to direct the current toward the heart. In humans, the anterior apical right ventricular myocardium is closest to the chest wall. Positioning of an electrode in a small, thin human in the region of the left nipple with the other electrode near the sternal notch may simulate our Position A and could potentially achieve comparable proximities of electrodes to the heart. Avoidance of this position would greatly reduce any concern for induction of ventricular arrhythmias. Our data also indicate that cocaine decreases the vulnerability to ventricular arrhythmias with electrical stun gun use.
Study limitations. Our study was performed in anesthetized pigs for obvious ethical reasons. It is conceivable that application of a Taser in a nonanesthetized state, similar to a real-life situation, could activate a higher sympathetic tone, which may have a different effect. However, the extent of such an increase in sympathetic tone is hard to estimate because human studies have shown a minimal increase of heart rate (mean 20 beats/min) caused by the NMI application (27). The pigs used in this study also had no particular cardiac abnormality. It is possible that structural heart disease may affect the inducibility of arrhythmias by NMI devices. Such inducibility may interact differently with the presence of cocaine. Lastly, although the findings were quite consistent from animal to animal, the total number of animals used in this study was small.
Conclusions. Cocaine increased the VFT of NMI applications in all dart locations tested and actually reduced vulnerability to VF. Induction of VF at higher output than standard NMI applications seems to be related to myocardial capture.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Nanthakumar MD, S. Masse PEng MASc, K. Umapathy PhD, P. Dorian MD, E. Sevaptsidis, and M. Waxman MD Cardiac stimulation with high voltage discharge from stun guns Can. Med. Assoc. J., May 20, 2008; 178(11): 1451 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lakkireddy, A. Khasnis, J. Antenacci, K. Ryshcon, M. K. Chung, D. Wallick, W. Kowalewski, D. Patel, H. Mlcochova, A. Kondur, et al. Do electrical stun guns (TASER-X26(R)) affect the functional integrity of implantable pacemakers and defibrillators? Europace, July 1, 2007; 9(7): 551 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Tchou Reply J. Am. Coll. Cardiol., February 13, 2007; 49(6): 733 - 733. [Full Text] [PDF] |
||||
![]() |
J. J. Pippin Taser Research in Pigs Not Helpful J. Am. Coll. Cardiol., February 13, 2007; 49(6): 731 - 732. [Full Text] [PDF] |
||||
![]() |
M. W. Kroll, H. Calkins, and R. M. Luceri Electronic Control Devices and the Clinical Milieu J. Am. Coll. Cardiol., February 13, 2007; 49(6): 732 - 732. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |